The problem with repurposing: Is there really an alternative to Big Pharma for developing new drugs for multiple sclerosis?
Volume
4
Pagination
3 - 5
DOI
10.1016/j.msard.2014.11.005
Journal
MULTIPLE SCLEROSIS AND RELATED DISORDERS
Issue
ISSN
2211-0348